In 2023, male neoplasms mortality stood at a standardised rate of 233 deaths per hundred thousand men. The forecasted data from 2024 to 2028 indicates a year-on-year decline in neoplasms mortality rates. Specifically, from 2024 to 2025, the rate is projected to decrease by 1.30%, followed by a decline of 1.32% from 2025 to 2026. The reduction continues with a decrease of 1.29% from 2026 to 2027 and 1.26% from 2027 to 2028. Over the five-year forecast period, the compound annual growth rate (CAGR) for neoplasms mortality is anticipated to be -1.30%, suggesting a steady decline.
Key future trends to watch for include advancements in early detection and treatment methods, potential changes in healthcare policies, and shifts in lifestyle factors that could influence overall cancer mortality rates. Additionally, monitoring the impact of new medical technologies and public health initiatives will be crucial in understanding their effect on reducing neoplasm-related deaths.
